TY - JOUR
T1 - Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp
AU - Verkerk, Arie O.
AU - Veerman, Christiaan C.
AU - Zegers, Jan G.
AU - Mengarelli, Isabella
AU - Bezzina, Connie R.
AU - Wilders, Ronald
PY - 2017
Y1 - 2017
N2 - Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for studying inherited cardiac arrhythmias and developing drug therapies to treat such arrhythmias. Unfortunately, until now, action potential (AP) measurements in hiPSC-CMs have been hampered by the virtual absence of the inward rectifier potassium current (I-K1) in hiPSC-CMs, resulting in spontaneous activity and altered function of various depolarising and repolarising membrane currents. We assessed whether AP measurements in ventricular-like and atrial-like hiPSC-CMs could be improved through a simple, highly reproducible dynamic clamp approach to provide these cells with a substantial I-K1 (computed in real time according to the actual membrane potential and injected through the patch-clamp pipette). APs were measured at 1 Hz using perforated patch-clamp methodology, both in control cells and in cells treated with all-trans retinoic acid (RA) during the differentiation process to increase the number of cells with atrial-like APs. RA-treated hiPSC-CMs displayed shorter APs than control hiPSC-CMs and this phenotype became more prominent upon addition of synthetic I-K1 through dynamic clamp. Furthermore, the variability of several AP parameters decreased upon I-K1 injection. Computer simulations with models of ventricular-like and atrial-like hiPSC-CMs demonstrated the importance of selecting an appropriate synthetic I-K1. In conclusion, the dynamic clamp-based approach of I-K1 injection has broad applicability for detailed AP measurements in hiPSC-CMs
AB - Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for studying inherited cardiac arrhythmias and developing drug therapies to treat such arrhythmias. Unfortunately, until now, action potential (AP) measurements in hiPSC-CMs have been hampered by the virtual absence of the inward rectifier potassium current (I-K1) in hiPSC-CMs, resulting in spontaneous activity and altered function of various depolarising and repolarising membrane currents. We assessed whether AP measurements in ventricular-like and atrial-like hiPSC-CMs could be improved through a simple, highly reproducible dynamic clamp approach to provide these cells with a substantial I-K1 (computed in real time according to the actual membrane potential and injected through the patch-clamp pipette). APs were measured at 1 Hz using perforated patch-clamp methodology, both in control cells and in cells treated with all-trans retinoic acid (RA) during the differentiation process to increase the number of cells with atrial-like APs. RA-treated hiPSC-CMs displayed shorter APs than control hiPSC-CMs and this phenotype became more prominent upon addition of synthetic I-K1 through dynamic clamp. Furthermore, the variability of several AP parameters decreased upon I-K1 injection. Computer simulations with models of ventricular-like and atrial-like hiPSC-CMs demonstrated the importance of selecting an appropriate synthetic I-K1. In conclusion, the dynamic clamp-based approach of I-K1 injection has broad applicability for detailed AP measurements in hiPSC-CMs
U2 - https://doi.org/10.3390/ijms18091873
DO - https://doi.org/10.3390/ijms18091873
M3 - Article
C2 - 28867785
SN - 1422-0067
VL - 18
JO - International journal of molecular sciences
JF - International journal of molecular sciences
IS - 9
M1 - 1873
ER -